CONTINUING EDUCATION (2)
CE Article: Review of Fluconazole Treatment and Prophylaxis for Invasive Candidiasis in Neonates

Date: 05/21/2021

Review of Fluconazole Treatment and Prophylaxis for Invasive Candidiasis in Neonates
Hornik CD, Bondi DS, Greene NM, Cober MP, Barnabas J. Review of Fluconazole Treatment and Prophylaxis for Invasive Candidiasis in Neonates. J Pediatr Pharmacol Ther 2021;26(2):115–122 DOI: 10.5863/1551-6776-26.2.115

Learning Objectives for Pharmacists

At the end of this session, participants will be able to:

  1. Identify common species of candida that cause infection in neonates

  2. Describe the dosing strategies of fluconazole when used for prophylaxis and treatment

  3. Understand risks associated with different antifungals

Course Details and Instructions

Accreditation

PPA has accredited this knowledge-based article for 1.0 contact hours (0.10 CEUs) of continuing education credit for pharmacists. UAN #:0180-0000-21-013-H01-P. The Pediatric Pharmacy Association is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. In order to receive credit, participants must register for the program, read the article, pass a post-test, and fill out a post-program survey. Program expires in December 2024

Webinar and online programs are 100% supported through program registration fees and PPA membership dues, and is not supported by Industry.

 

BCPPS Recertification Credit is also available for this activity. Participants will be required to complete an evaluation and pass an exam in order to receive their certificate. Once the exam is passed, participants will receive 1 hour BCPPS credit. Valid through May 20, 2022.